Evidence map›Paper›PMID 32801170›Full record

ArticleApplied and environmental microbiology2020

Ribosome-Engineered

Minori Ishida, Fu Namai, Suguru Shigemori, Shoko Kajikawa, Masami Tsukagoshi, Takashi Sato, Tasuku Ogita, Takeshi Shimosato

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Minori Ishida *Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Fu Namai *Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Suguru Shigemori *Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Shoko KajikawaDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Masami TsukagoshiDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Takashi SatoDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Tasuku OgitaDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.
Takeshi ShimosatoDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan shimot@shinshu-u.ac.jp.ORCID 0000-0001-8132-1911
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differences in individual host responses have emerged as an issue regarding the health benefits of probiotics. Here, we applied ribosome engineering (RE) technology, developed in an actinomycete study, to

Indexed as

Bacterial AdhesionBacterial ProteinsBioengineeringColonGlyceraldehyde-3-Phosphate DehydrogenasesHumansLacticaseibacillus rhamnosusMucinsRibosomesBacterial ProteinsGlyceraldehyde-3-Phosphate DehydrogenasesMucinsGAPDHhuman colonic mucinLacticaseibacillus rhamnosus GGribosome engineering

Identifiers

PMID32801170
PMCPMC7531950
OpenAlexW3048817966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.